Carlo Pincelli

Company: PinCell

Job title: Chief Medical Officer and Professor of Dermatology

Seminars:

Late-Breaking Preclinical Data: Novel Anti-FasL mAb for Severe Dermatologic Conditions 9:00 am

Discover a novel non-immunosuppressive approach targeting FasL in severe blistering conditions with significant mortality rates  Explore preclinical efficacy data from validated disease models using proprietary humanised FasL mouse platform  Understand unique clinical considerations for underserved ‘orphan’ dermatology indications Read more

day: Day One